Science Explorer Interactive view Map
Company · Auckland · New Zealand

Kode Biotech (New Zealand)

Research works
5
fractional, all time
Citations
118
22.3 per fractional work
Top-10% rate
0.0%
record average 16.5%
Open access
29%
world 28%

Not ranked overall: Kode Biotech (New Zealand) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Which research topics does Kode Biotech (New Zealand) publish most on?

By volume in 2022–2025: Erythrocyte Function and Pathophysiology, Sex work and related issues, Glycosylation and Glycoproteins Research and Carbohydrate Chemistry and Synthesis.

  1. 1 Erythrocyte Function and Pathophysiology Physiology 0 works
  2. 2 Sex work and related issues Sociology and Political Science 0 works
  3. 3 Glycosylation and Glycoproteins Research Molecular Biology 0 works
  4. 4 Carbohydrate Chemistry and Synthesis Organic Chemistry 0 works
  5. 5 Syphilis Diagnosis and Treatment Physiology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available29.0%not open71.0%

World: 28% of research is openly available.

with international co-authors71.7%domestic only28.3%

World: 19% is written across borders.

How has Kode Biotech (New Zealand)'s research output changed?

20102015
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Auckland

All research institutions in Auckland

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.